Approval · Notice of Compliance 28025 · 2022
AMIODARONE: Notice of Compliance 28025
Issued April 26, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28025
- Date
- April 26, 2022
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Labelling Update (to Match Licensor)
- Canadian reference product
- CORDARONE (Wyeth-Ayerst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMIODARONE | Not yet assigned | — |
Medicinal ingredients
- AMIODARONE HYDROCHLORIDE 200 MG per TAB